News

BioCentury, Kalamazoo, MI: 11/23/2009
Metabolic Solutions: PPAR-less sensitization (PDF)

Press Release, Kalamazoo, MI: 10/12/2009
Metabolic Solutions Development Company To Test Potential Treatment For Alzheimer’s. (PDF)

The Kalamazoo Gazette, Kalamazoo, MI: 10/11/2009
Kalamazoo-based Metabolic Solutions to receive $1.5 million from NIH

Press Release, Kalamazoo, MI: 8/4/09
Metabolic Solutions Development Company Names Chief Executive Officer. (PDF)

Press Release, Kalamazoo, MI: 5/14/09
Metabolic Solutions Development Company announces preliminary results from Phase IIa clinical trial. (PDF)

Press Release, Kalamazoo, MI: 4/29/09
Metabolic Solutions Development Company secures more than $10 Million for further development of its diabetes drug portfolio. (PDF)

The Grand Rapids Press, Grand Rapids, MI: 11/16/08
Local lab claims success in diabetes treatment, aims to make next blockbuster drug.

The Kalamazoo Gazette, Kalamazoo, MI: 10/17/08
Sugar fighter: Kalamazoo company Metabolic Solutions on the verge of a diabetes treatment breakthrough

Channel 3, WWMT.com, Kalamazoo, MI: 10/9/08, 11 pm
Breaking News: State Grant Grows Jobs (WMV)

Press Release, Lansing, MI: 10/08/08
21st Century Jobs Fund Awards $30 Million to 17 High-Tech Firms

Press Release, Kalamazoo, MI: 09/30/08
West Michigan drug research company set to begin major clinical trial of diabetes drug (PDF)

Press Release, Kalamazoo, MI: 05/28/08
Dr. John Landis joins Board of Directors of Metabolic Solutions Development Co. (PDF)

Interview with Jerry Colca, Ph.D., Kalamazoo, MI: 05/18/08
Michigan First – Business First (WMV)

Resources

IDF World Diabetes Congress Poster, Montreal 2009
A PPAR-Sparing Insulin Sensitizer is Effective in Type 2 Diabetic Patients Without Causing Weight Gain (PDF)

MD Conference Express: Diabetes, EASD Highlights, 09/08, excerpt
Mitoglitazone and PPAR-sparing Insulin Sensitizers (PDF)

EASD Abstract, Roma 2008
PPAR-sparing insulin sensitizers; path for development and clinical evaluation (PDF)